Prices for insulin, the essential drug for treating diabetes, have plummetted to their lowest levels in a decade following a ...
The University of California, San Francisco states that, as a general rule, 1 unit of rapid-acting insulin will process anywhere from 12 to 15 grams of carbohydrates. A bolus dose may also be used ...
The announcement that inhaled insulin will soon be available in India has understandably generated a lot of excitement and ...
Even as the global diabetes war continues to rage, Indian pharmaceutical companies are emerging from the shadows, armed with ...
Hosted on MSN1mon
Cipla set to bring Afrezza, 1st inhalable insulin since Exubera, to Indian markets by 2025New Delhi: India is set to see the launch of Afrezza—the only rapid-acting, inhaled insulin to help control high blood sugar in adults with type 1 or type 2 diabetes—ten years after the ...
Inhaled insulin was noninferior to usual care in glycemic control outcomes after 17 weeks among patients with type 1 diabetes.
Insulin lispro, the rapid-acting component of Humalog Mix75/25, has been shown to be equipotent to Regular human insulin on a molar basis. Instruct patients on diet, exercise, blood or urine ...
The INHALE-1 study is a 26-week, open-label clinical trial that randomized 230 subjects to one of two groups: Afrezza or multiple daily injections (MDI) of rapid acting insulin analog (RAA ...
(RTTNews) - MannKind Corporation (MNKD) Monday reported positive six-month results from its Phase 3 INHALE-1 study of Afrezza Inhalation Powder, a rapid-acting inhaled human insulin, in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback